Synlogic Inc SYBX

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Why Synlogic (SYBX) Stock Is Down Nearly 50% Today

on MSN ago, source:

Synlogic Inc (NASDAQ:SYBX) shares are trading lower by 48.4% to $1.78 Friday afternoon after the company announced it will ...

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results

1mon ago, source: Business Insider

CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today ...

Hold Rating on Synlogic Amidst Lead Program Discontinuation and Strategic Uncertainties

1mon ago, source: Business Insider

Begin your TipRanks Premium journey today. Synlogic (SYBX) Company Description: Synlogic, Inc. is a clinical-stage biopharmaceutical company, which engages in drug discovery and development of ...

Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates

1mon ago, source: Yahoo Finance

Synlogic, Inc. (SYBX) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $3.60 per share a year ago. These figures ...

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

24d ago, source: ADVFN

Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, announced today the decision to discontinue Synpheny-3 ...

Synlogic, Inc. (0A8U.L)

1mon ago, source: Yahoo Finance

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com... Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 19.23% and 80 ...

Synlogic, Inc. (MIN.F)

2mon ago, source: Yahoo Finance

Feb. 20, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today announced that its Board of ...

Synlogic, Inc. (SYBX)

3d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results

1mon ago, source: ADVFN

Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the fourth quarter and full ...

Synlogic Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...